Nutex Health Inc. (NUTX) exhibits 50.8% gross margins and 85.0% return on invested capital within Consumer Discretionary (Business Services), balanced against a 4.6x enterprise multiple and 4.8% implied options volatility.
Sustained 50.8% gross profitability converts into 31.5% operating margin and 85.0% ROIC, outpacing sector cost of capital.
ROIC: 85.0% // GM: 50.8%YoY revenue trajectory of +82.4% paired with 17.07% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +82.4% // FCF YLD: 17.07%Altman Z-Score of 3.75 and Piotroski F-Score of 9/9 indicate low near-term refinancing stress.
ALTMAN Z: 3.75 // F-SCORE: 9/9Trading at 20.3x trailing P/E (17.1x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 20.3x // EV/EBITDA: 4.6xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $210.10 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Business Services require continuous execution to defend 8.1% net margins.
NET MARGIN: 8.1% // D/E: 0.09x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for NUTX & activate live FRED threshold breach alerts.